| Combination of | |
|---|---|
| Hydrocodone | Opioid agonist |
| Guaifenesin | Expectorant |
| Clinical data | |
| Trade names | Obredon, Flowtuss, others |
| AHFS/Drugs.com | |
| License data | |
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| KEGG | |
Hydrocodone/guaifenesin, sold under the brand nameObredon among others, is afixed-dose combination medication used for the treatment ofcough.[2] It containshydrocodone, as thebitartrate, anopioid agonist; andguaifenesin, anexpectorant.[2] It is takenby mouth.[2]
Hydrocodone/guaifenesin was approved for medical use in the United States in 2014.[3][4]
In the US, the label for hydrocodone/guaifenesin contains ablack box warning about addiction, abuse, and misuse.[2]
 | Thisdrug article relating to therespiratory system is astub. You can help Wikipedia byadding missing information. |
